Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial
…, J Rowlands, V Ruffulo, C Soave, L Titti… - The Lancet …, 2023 - thelancet.com
Background From early in the COVID-19 pandemic, evidence suggested a role for cytokine
dysregulation and complement activation in severe disease. In the TACTIC-R trial, we …
dysregulation and complement activation in severe disease. In the TACTIC-R trial, we …
[HTML][HTML] Development and implementation of a customised rapid syndromic diagnostic test for severe pneumonia
…, P Polgarova, J Brown, L Titti… - Wellcome open …, 2021 - ncbi.nlm.nih.gov
Background: The diagnosis of pneumonia has been hampered by a reliance on bacterial
cultures which take several days to return a result, and are frequently negative. In critically ill …
cultures which take several days to return a result, and are frequently negative. In critically ill …
[PDF][PDF] peer review: 1 approved with reservations
…, E Heasman-Hunt, P Polgarova, J Brown, L Titti… - 2022 - researchgate.net
Background: The diagnosis of pneumonia has been hampered by a reliance on bacterial
cultures which take several days to return a result, and are frequently negative. In critically ill …
cultures which take several days to return a result, and are frequently negative. In critically ill …
[CITATION][C] Development and implementation of a customised rapid syndromic diagnostic test for severe pneumonia (preprint)
…, E Heasman-Hunt, P Polgarova, J Brown, L Titti… - 2020
Sul ruolo delle sostanze alimentari nei testi medici mesopotamici
FM Fales - Sul ruolo delle sostanze alimentari nei testi medici …, 2012 - torrossa.com
… Eventuali correlazioni o scelte alternative tra le impostazioni e le metodiche curative
descritte in tutti questi insiemi documentari vanno verificate caso per caso; come si sa, infatti, la …
descritte in tutti questi insiemi documentari vanno verificate caso per caso; come si sa, infatti, la …
